Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Thal-sns-032 | 2139287-33-3 | >98.0% | 869.02 g·mol⁻¹ | C40H52N8O10S2 | 1MG
SDP

Catalog No. 5000235251
Encompass_Preferred

THAL-SNS-032 is a selective CDK9 degrader PROTAC consisting of the CDK-binding ligand SNS-032 linked to a thalidomide-derived cereblon (CRBN) E3 ligase ligand. It promotes CRBN-dependent ubiquitination and proteasomal degradation of CDK9 and is supplied as a high-purity research compound for in vitro target degradation and mechanistic studies.

  • Selective CDK9 degradation via cereblon recruitment.
  • Reported potency with EC50 ≈ 4 nM in cell-based assays.
  • High purity (≥98% by HPLC) suitable for research use.
  • Molecular weight 869.02 g·mol⁻¹ and defined molecular formula.
  • Designed for use in mechanistic and pharmacology studies of targeted protein degradation.

Catalog No. 50-002-35251 Supplier Medchemexpress LLC Supplier No. HY1239371MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

THAL-SNS-032 is a selective CDK9 degrader PROTAC consisting of the CDK-binding ligand SNS-032 linked to a thalidomide-derived cereblon (CRBN) E3 ligase ligand. It promotes CRBN-dependent ubiquitination and proteasomal degradation of CDK9 and is supplied as a high-purity research compound for in vitro target degradation and mechanistic studies.

  • Selective CDK9 degradation via cereblon recruitment.
  • Reported potency with EC50 ≈ 4 nM in cell-based assays.
  • High purity (≥98% by HPLC) suitable for research use.
  • Molecular weight 869.02 g·mol⁻¹ and defined molecular formula.
  • Designed for use in mechanistic and pharmacology studies of targeted protein degradation.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.